BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 1, Issue 5
  • This Article
(0) (0)
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (5485)
All Articles published online
Item 
Count 
PDF473
HTML3799
Figures (1-3)645
Tables (1-2)569
 Sum=5486
Nov 15, 2010 (publication date) through May 9, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article
©2010 Baishideng Publishing Group Co.
World J Diabetes. Nov 15, 2010; 1(5): 153-160
Published online Nov 15, 2010. doi: 10.4239/wjd.v1.i5.153
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Mean (± standard error) hemoglobin A1c during 24-wk treatment with vildagliptin/pioglitazone combination (100/30 mg q. d. circles; 50/15 mg q.d. triangles), vildagliptin 100 mg q.d. (squares), or pioglitazone 30 mg q.d. (diamonds) in a Korean population. HbA1c: hemoglobin A1c.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Mean (± standard error) fasting plasma glucose during 24-wk treatment with vildagliptin/pioglitazone combination (100/30 mg q. d. circles; 50/15 mg q.d. triangles), vildagliptin 100 mg q.d. (squares), or pioglitazone 30 mg q.d. (diamonds) in a Korean population. FPG: fasting plasma glucose.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Mean (± standard error) change in the indicated prandial variables at endpoint, following treatment with vildagliptin/pioglitazone combination (100/30 mg q. d. or 50/15 mg q.d.), vildagliptin 100 mg q.d., or pioglitazone 30 mg q.d., in patients that volunteered for the meal test. aSignificant difference compared with pioglitazone 30 mg q.d. monotherapy.
Write to the Help Desk
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.